BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

142 related articles for article (PubMed ID: 13966202)

  • 21. THE EFFECT OF TUMOUR DOSAGE ON THE BLOOD CONTENT OF EHRLICH'S ASCITES CARCINOMA.
    HARTVEIT F
    Br J Cancer; 1963 Sep; 17(3):478-81. PubMed ID: 14062495
    [No Abstract]   [Full Text] [Related]  

  • 22. A SUBCELLULAR TRANSMISSIBLE AGENT FROM EHRLICH CARCINOMA CELLS PRODUCING ASCITES TUMORS IN MICE.
    TOLNAI S; SCANTLAND R; MORGAN JF
    Proc Can Cancer Conf; 1963; 5():175-89. PubMed ID: 14278857
    [No Abstract]   [Full Text] [Related]  

  • 23. [THE CHANGES IN ADENOVIRUS, TYPE 3, AFTER ITS INOCULATION IN MICE WITH EHRLICH'S ASCITES CARCINOMA].
    NASTAC E; ISAIA G; DONA G; LUNGU M; RUTTER G; POPESCU G
    Rev Sci Med; 1963; 8():147-50. PubMed ID: 14109302
    [No Abstract]   [Full Text] [Related]  

  • 24. [BIOLOGICAL EFFECTS OF MICROWAVE RADIATION. EFFECTS OF MICROWAVE IRRADIATION ON EHRLICH'S ASCITES CARCINOMA CELLS].
    HORAI H
    Nihon Igaku Hoshasen Gakkai Zasshi; 1964 May; 24():105-6. PubMed ID: 14175338
    [No Abstract]   [Full Text] [Related]  

  • 25. [Action of a chelating product (calcium disodium tetracemate) on the evolution of experimental infections with several viruses and on the development of some tumors].
    Balmuş G
    Stud Cercet Inframicrobiol; 1967; 18(1):29-37. PubMed ID: 4292525
    [No Abstract]   [Full Text] [Related]  

  • 26. EFFECT OF GRISEOFULVIN-METHOTREXATE COMBINATION TREATMENT UPON EHRLICH'S ASCITES TUMOR GROWTH.
    WALKER EE
    Surg Forum; 1964; 15():360-2. PubMed ID: 14189408
    [No Abstract]   [Full Text] [Related]  

  • 27. The in vitro demonstration of a cytotoxic factor in Ehrlich's ascites carcinoma.
    HARTVEIT F
    Acta Pathol Microbiol Scand; 1963; 58():10-6. PubMed ID: 13953176
    [No Abstract]   [Full Text] [Related]  

  • 28. [CONTRIBUTIONS TO THE STUDY OF THE CYTOMORPHOLOGICAL CHANGES IN EHRLICH'S ASCITES CARCINOMA UNDER THE INFLUENCE OF RIBONUCLEASE AND DESOXYRIBONUCLEASE].
    CIPLEA AG; SORU E; BANU I
    Stud Cercet Med Interna; 1964; 92():683-7. PubMed ID: 14242691
    [No Abstract]   [Full Text] [Related]  

  • 29. Sex differences in the intraperitoneal growth of Ehrlich's ascites carcinoma.
    HARTVEIT F
    Acta Pathol Microbiol Scand; 1963; 58():25-32. PubMed ID: 13953178
    [No Abstract]   [Full Text] [Related]  

  • 30. THE INFLUENCE OF THE EHRLICH'S ASCITES TUMOR ON THE REGENERATION OF HEMATOPOIESIS IN IRRADIATED MICE.
    JURASKOVA V; TKADLECEK L; DRASIL V
    Neoplasma; 1964; 11():591-8. PubMed ID: 14271459
    [No Abstract]   [Full Text] [Related]  

  • 31. Brain tumors induced with Rous sarcoma virus, Schmidt-Ruppin strain. 2. Rous tumor specific transplantation antigen in subcutaneously passaged mouse brain tumors.
    Kumanishi T; Yamamoto T
    Jpn J Exp Med; 1970 Apr; 40(2):79-86. PubMed ID: 4318037
    [No Abstract]   [Full Text] [Related]  

  • 32. STUDIES ON MALIGNOLIPIN. XI. EFFECT OF MALIGNOLIPIN ON THE SURVIVAL PERIOD OF MICE BEARING EHRLICH'S ASCITES CANCER. PRELIMINARY REPORT.
    KOSAKI T; MURAKI K; NAGAYASU N; NAKAGAWA S
    Mie Med J; 1963; 13():43-9. PubMed ID: 14218692
    [No Abstract]   [Full Text] [Related]  

  • 33. [The effect of several viruses and cytostatic products on pulmonary tumors induced by intravenous injection of Ehrlich's ascites in mice].
    COSTACHEL O; ILIE B
    Rev Sci Med; 1961; 6():145-8. PubMed ID: 13881599
    [No Abstract]   [Full Text] [Related]  

  • 34. Immunization against Ehrlich's ascites carcinoma with streptomycin complexes from tumour cells.
    POLGLASE WJ
    Nature; 1963 Jan; 197():301-2. PubMed ID: 13944309
    [No Abstract]   [Full Text] [Related]  

  • 35. SURVIVAL OF EHRLICH'S ASCITES CARCINOMA CELLS AT HIGH ULTRA-CENTRIFUGAL FORCES.
    MOLOMUT N; PADNOS M; SATORY V; GROSS L
    Nature; 1964 Aug; 203():740-2. PubMed ID: 14207272
    [No Abstract]   [Full Text] [Related]  

  • 36. Screening of the cytotoxic action of fungus filtrates on Ehrlich's ascites carcinoma, utilizing 14 C-labelled precursors.
    Fuska J; Miko M; Nemec P; Drobnica L
    Neoplasma; 1971; 18(6):631-6. PubMed ID: 5160902
    [No Abstract]   [Full Text] [Related]  

  • 37. [On sensitivity to sarcolysine of Ehrlich's ascites tumors in mice "vaccinated" with treated tumor cells from animals previously treated with sarcolysine alone or with other antineoplastic drugs (thioguanine, actinomycin D)].
    Bonmassar E; Melan F; Testorelli C
    Arch Ital Patol Clin Tumori; 1968; 11(1):229-44. PubMed ID: 5745130
    [No Abstract]   [Full Text] [Related]  

  • 38. Inhibition of growth of Ehrlich ascites tumors in ICR-Ha Swiss mice by isocyanates.
    Moos GE; Maguire JA; Kitchlew TZ; Swyers WA; Volk PZ; Croft JR; Quigley MJ; Fries JR; Oser NA; Anderson LJ
    Cancer Res; 1971 Jul; 31(7):937-41. PubMed ID: 5560387
    [No Abstract]   [Full Text] [Related]  

  • 39. [EFFECT OF NEUTRONS AND X-RAYS ON THE CELLS OF EHRLICH'S ASCITES TUMOR].
    SILINI G; HORNSEY S
    Tumori; 1964; 50():3-12. PubMed ID: 14137307
    [No Abstract]   [Full Text] [Related]  

  • 40. Enhanced development of reticulum cell neoplasms following subcutaneous inoculations of cell-free filtrate of Ehrlich's ascites carcinoma. A study in adult, female mice.
    Myking AO
    Acta Pathol Microbiol Scand A; 1974 Jul; 82(4):564-70. PubMed ID: 4604431
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.